Nuclera is a venture-backed biotech company based in Cambridge, UK, with significant operations in Boston, USA. The company is dedicated to accelerating drug discovery by providing rapid and easy access to functional proteins through its innovative eProtein Discovery™ benchtop system. Nuclera focuses on optimizing protein expression and purification in research labs, aiming to enhance the efficiency of scientific research. With a commitment to continuous improvement and a dynamic work environment, Nuclera seeks to empower its team members to thrive in a fast-paced biotech landscape.